Pharmacological treatment of exertional dyspnoea in stable COPD patients

Monaldi Archives for Chest Disease

Volumn 52, Issue 4, 1997, Pages 354-362

  Melani, A S ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Dyspnoea

Indexed keywords

ALPRAZOLAM; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUSPIRONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIAMORPHINE; DIAZEPAM; DIHYDROCODEINE; MORPHINE; OPIATE; PROCHLORPERAZINE; PROMETHAZINE; PSYCHOTROPIC AGENT; SALBUTAMOL; THEOPHYLLINE;

ADDICTION; CHEMOPROPHYLAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DROWSINESS; DYSPNEA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL LITERATURE; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT;

EID: 0030732668     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. American Thoracic Society. - Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152 Suppl.: 77-120.
2. European Respiratory Society Consensus Statement. - Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.